Div. of Gastroenterology and Hepatology,
Dept. of Internal Medicine III,
Vienna Hepatic Hemodynamic Laboratory,
Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III
Philipp Schwabl has not added Biography.
If you are Philipp Schwabl and would like to personalize this page please email our Author Liaison for assistance.
Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
Journal of hepatology Nov, 2009 | Pubmed ID: 19726100
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Gut Nov, 2013 | Pubmed ID: 23250049
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Liver international : official journal of the International Association for the Study of the Liver Apr, 2013 | Pubmed ID: 23331709
Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
Gastroenterology Jun, 2014 | Pubmed ID: 24631577
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
Liver international : official journal of the International Association for the Study of the Liver Mar, 2015 | Pubmed ID: 24905495
New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.
Liver international : official journal of the International Association for the Study of the Liver Feb, 2015 | Pubmed ID: 24953516
Response-guided boceprevir-based triple therapy in HIV/HCV-coinfected patients: the HIVCOBOC-RGT study.
The Journal of infectious diseases Mar, 2015 | Pubmed ID: 25214517
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.
PloS one , 2014 | Pubmed ID: 25265505
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
PloS one , 2014 | Pubmed ID: 25369194
Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.
Liver international : official journal of the International Association for the Study of the Liver Sep, 2015 | Pubmed ID: 25644943
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.
PloS one , 2015 | Pubmed ID: 25646812
Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study.
Journal of gastroenterology and hepatology Nov, 2015 | Pubmed ID: 25967931
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
PloS one , 2015 | Pubmed ID: 26599080
Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure.
Wiener klinische Wochenschrift Jun, 2016 | Pubmed ID: 26659706
Advances in the management of HIV/HCV coinfection.
Hepatology international May, 2016 | Pubmed ID: 26758592
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease.
AIDS (London, England) Apr, 2016 | Pubmed ID: 26760453
Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP).
Journal of hepatology 06, 2016 | Pubmed ID: 26916528
Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
Journal of gastroenterology and hepatology Jan, 2017 | Pubmed ID: 27164413
The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites.
Liver international : official journal of the International Association for the Study of the Liver 11, 2016 | Pubmed ID: 27169985
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.
Journal of hepatology 10, 2016 | Pubmed ID: 27242316
Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study.
Medicine Jul, 2016 | Pubmed ID: 27399090
Metabolic preconditioning protects BSEP/ABCB11 mice against cholestatic liver injury.
Journal of hepatology Jan, 2017 | Pubmed ID: 27593105
Liver Capsule: FXR agonists against liver disease.
Hepatology (Baltimore, Md.) 11, 2016 | Pubmed ID: 27635933
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.
Journal of hepatology Apr, 2017 | Pubmed ID: 27993716
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna.
Wiener klinische Wochenschrift Aug, 2017 | Pubmed ID: 28130599
Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.
Scandinavian journal of gastroenterology Sep, 2017 | Pubmed ID: 28532189
Novel treatment options for portal hypertension.
Gastroenterology report May, 2017 | Pubmed ID: 28533907
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.
Wiener klinische Wochenschrift Feb, 2018 | Pubmed ID: 28744597
Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Dec, 2017 | Pubmed ID: 28869158
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).
Wiener klinische Wochenschrift Nov, 2017 | Pubmed ID: 29063233
ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 06, 2018 | Pubmed ID: 29091351
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.
PloS one , 2018 | Pubmed ID: 29315304
Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.
European radiology Dec, 2018 | Pubmed ID: 29858640
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Wiener klinische Wochenschrift Jun, 2018 | Pubmed ID: 29916054
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.
Scientific reports Jun, 2018 | Pubmed ID: 29921982
Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.
Liver international : official journal of the International Association for the Study of the Liver 01, 2019 | Pubmed ID: 30107095
Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis.
Ultrasound in medicine & biology 12, 2018 | Pubmed ID: 30241728
Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 08, 2019 | Pubmed ID: 30862438
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort.
Alimentary pharmacology & therapeutics 05, 2019 | Pubmed ID: 30980420
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
Journal of gastroenterology and hepatology Dec, 2019 | Pubmed ID: 31062417
High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients.
United European gastroenterology journal 05, 2019 | Pubmed ID: 31065368
Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.
AIDS patient care and STDs 05, 2019 | Pubmed ID: 31067123
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
Digestive diseases and sciences 12, 2019 | Pubmed ID: 31209721
Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.
United European gastroenterology journal 06, 2019 | Pubmed ID: 31210943
Vascular Targets for the Treatment of Portal Hypertension.
Seminars in liver disease 11, 2019 | Pubmed ID: 31315135
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy.
Hepatology (Baltimore, Md.) Mar, 2020 | Pubmed ID: 31365764
Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease.
Liver international : official journal of the International Association for the Study of the Liver Jan, 2020 | Pubmed ID: 31444993
Detection of Various Microplastics in Human Stool: A Prospective Case Series.
Annals of internal medicine 10, 2019 | Pubmed ID: 31476765
HCV-RNA is commonly detectable in rectal and nasal fluids of patients with high viremia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Sep, 2019 | Pubmed ID: 31562817
The impact of hepatic steatosis on portal hypertension.
PloS one , 2019 | Pubmed ID: 31693695
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.
Liver international : official journal of the International Association for the Study of the Liver Feb, 2020 | Pubmed ID: 31967400
Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis.
Scientific reports Feb, 2020 | Pubmed ID: 32071351
Iron deficiency induced thrombocytosis increases thrombotic tendency in rats.
Haematologica Feb, 2020 | Pubmed ID: 32079699
Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
United European gastroenterology journal Apr, 2020 | Pubmed ID: 32213023
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
Liver international : official journal of the International Association for the Study of the Liver May, 2020 | Pubmed ID: 32358998
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados